Emtricitabine / Tenofovir | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Emtricitabine / Tenofovir
Annual Reports

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Emtricitabine / Tenofovir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 17 USDMF, 2 JDMF, 14 EU WC, 6 KDMF, 19 NDC API, 16 Listed Suppliers, $ API Reference Price

31 API Suppliers
17 USDMF
2 JDMF
14 EU WC
6 KDMF
19 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

171 FDF Dossiers, 52 FDA Orange Book, 32 Europe, 24 Canada, 52 South Africa, 11 Listed Dossiers

171 FDF Dossiers
52 FDA Orange Book
32 Europe
24 Canada
52 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE
CAPSULE;ORAL - 200MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 8 DKSH, 1 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 33 Controlled & Modified Release, 31 Direct Compression, 24 Thickeners and Stabilizers, 22 Disintegrants & Superdisintegrants, 22 Granulation, 18 Solubilizers, 16 Topical, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 12 Film Formers & Plasticizers, 11 Taste Masking, 11 Parenteral, 9 Empty Capsules, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 3 Rheology Modifiers

70 Fillers, Diluents & Binders
53 Coating Systems & Additives
33 Controlled & Modified Release
31 Direct Compression
24 Thickeners and Stabilizers
22 Disintegrants & Superdisintegrants
22 Granulation
18 Solubilizers
16 Topical
16 Lubricants & Glidants
14 Co-Processed Excipients
12 Film Formers & Plasticizers
11 Taste Masking
11 Parenteral
9 Empty Capsules
7 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
3 Rheology Modifiers

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 3 STOCK RECAP #PipelineProspector, 191 NEWS #PharmaBuzz

6 DATA COMPILATION #PharmaFlow
3 STOCK RECAP #PipelineProspector
191 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 29 Finished Drug Prices, 55 Annual Reports

5 US Medicaid Prescriptions
29 Finished Drug Prices
55 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

8 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

111 US Patents, 11 US Exclusivities, 2 Health Canada Patents

111 US Patents
11 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

3 USP
4 Others

$ API Ref.Price (USD/KG) : 347 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

55 All

01 4Atripla

02 4Biktarvy

03 1Complera /Eviplera

04 6Complera/Eviplera

05 8Descovy

06 5Genvoya

07 8Odefsey

08 2Revenue share - Symtuza

09 5Stribild

10 3Symtuza

11 9Truvada

List of Suppliers

Product Main Page

01

Brand Name : Symtuza

euroPLX 86 Munich

Not Confirmed

Brand Name : Symtuza

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Truvada

euroPLX 86 Munich

Not Confirmed

Brand Name : Truvada

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,448

2019 Revenue in Millions : 2,813

Growth (%) : -49

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Descovy

euroPLX 86 Munich

Not Confirmed

Brand Name : Descovy

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,861

2019 Revenue in Millions : 1,500

Growth (%) : 24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Atripla

euroPLX 86 Munich

Not Confirmed

Brand Name : Atripla

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 349

2019 Revenue in Millions : 600

Growth (%) : -42

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Complera/Eviplera

euroPLX 86 Munich

Not Confirmed

Brand Name : Complera/Eviplera

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 269

2019 Revenue in Millions : 406

Growth (%) : -34

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Odefsey

euroPLX 86 Munich

Not Confirmed

Brand Name : Odefsey

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,672

2019 Revenue in Millions : 1,655

Growth (%) : 1

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Genvoya

euroPLX 86 Munich

Not Confirmed

Brand Name : Genvoya

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Biktarvy

euroPLX 86 Munich

Not Confirmed

Brand Name : Biktarvy

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 7,259

2019 Revenue in Millions : 4,738

Growth (%) : 53

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Stribild

euroPLX 86 Munich

Not Confirmed

Brand Name : Stribild

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 196

2019 Revenue in Millions : 369

Growth (%) : -47

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Atripla

euroPLX 86 Munich

Not Confirmed

Brand Name : Atripla

euroPLX 86 Munich

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 145

2020 Revenue in Millions : 349

Growth (%) : -58

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?